B-LCL-HROC68 Cells
USUSD$800.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
一般資訊
| 說明 | B-LCL-HROC68 is an Epstein-Barr virus (EBV)-immortalized human B lymphoblastoid cell line established from tumor-infiltrating B cells (TiBc) isolated from a primary colorectal carcinoma designated HROC68. The parental tumor was a sporadic-type colorectal carcinoma resected from an adult male patient with advanced-stage disease. Fresh tumor tissue was mechanically dissociated, and B cells were cultured in the presence of EBV-containing supernatant derived from the B95/8 marmoset cell line, together with cyclosporin A to suppress outgrowth of T and NK cells. Long-term culture resulted in monoclonal expansion of B cells, as confirmed by immunoglobulin gene rearrangement analysis using BIOMED-2 multiplex PCR protocols, demonstrating a single dominant rearrangement pattern consistent with clonal origin. B-LCL-HROC68 secretes immunoglobulin G (IgG) as its exclusive isotype, with stable production over extended culture. In cell-based ELISA screening against allogeneic colorectal cancer cell lines (HROC24, HROC46, and HCT116), IgG derived from B-LCL-HROC68 demonstrated measurable tumor cell binding, with the strongest signal observed against HCT116 cells. However, subsequent flow cytometric validation indicated comparatively weak binding affinity relative to other TiBc-derived IgGs. These findings indicate that B-LCL-HROC68 represents a monoclonal, antigen-experienced tumor-infiltrating B-cell line capable of producing functional IgG with detectable tumor cell reactivity, providing a useful in vitro tool for investigating humoral immune responses within the colorectal carcinoma microenvironment and for potential identification of tumor-associated antigens. |
|---|---|
| 生物體 | Human |
| 組織 | Peripheral blood |
| 疾病 | Carcinoma |
| 同義詞 | Bc HROC68, TiBcHROC68 |
特徵
| 年齡 | 84 years |
|---|---|
| 性別 | Male |
| 族裔 | Caucasian |
| 形態學 | Round cells |
| 細胞類型 | B lymphoblast |
| 生長特性 | Suspension |
監管數據
| 引用 | B-LCL-HROC68 (Cytion catalog number 302078) |
|---|---|
| 生物安全等級 | 2 |
| NCBI_TaxID | 9606 |
| Cellosaurus 編號 | CVCL_A7UU |
生物分子資料
| 表面抗原 | CD19 |
|---|---|
| 病毒 | Transformant: EBV |
處理方式
| 培養基 | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| 營養補充品 | Supplement the medium with 10% heat-inactivated FBS |
| 傳代培養 | Gently homogenize the cell suspension in the flask by pipetting up and down, then take a representative sample to determine the cell density per ml. Dilute the suspension to achieve a cell concentration of 1 x 105 cells/ml with fresh culture medium, and aliquot the adjusted suspension into new flasks for further cultivation. |
| 冷凍培養基 | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| 細胞解凍與培養 |
|
| 培養環境 | 37°C, 5% CO2, humidified atmosphere. |
| 運送條款 | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| 儲存條件 | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
品質控制與分子分析
| 不孕症 | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|